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Angiotensin-converting enzyme (ACE) inhibitors represent a significant group of 
drugs primarily used in the treatment of hypertension and congestive heart failure. In 
this research, seven ACE inhibitors (enalapril, quinapril, fosinopril, lisinopril, cilazapril, 
ramipril, benazepril) were studied to evaluate the relationship between their protein 
binding and calculated (logP values) or ultra-high performance liquid chromatography-
tandem mass spectrometry (UHPLC-MS) and reversed-phase thin-layer chromatography 
(RP-TLC) lipophilicity data (ϕ0, CHI or C0 parameters, respectively). Their protein binding 
data varied from negligible (lisinopril) to 99% (fosinopril), while calculated logPKOWWIN 
values ranged from -0.94 (lisinopril) to 6.61 (fosinopril). The good correlations were 
established between protein binding values and logPKOWWIN data (R
2=0.7520) as well as 
between protein binding and chromatographic hydrophobicity data, ϕ0, CHI or C0 
parameters (R
2 were 0.6160, 0.6242 and 0.6547, respectively). The possible application 
of hydrophobicity data in drugs protein binding evaluation can be of great importance in 
drug bioavailability. Acta Medica Medianae 2012;51(4):13-18. 
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Introduction 
 
Absorption, distribution, metabolism and elimi-
nation (ADME) properties play a critical role in clinical 
success of drug candidates. Lipophilicity is one of the 
most important properties that significantly influence 
drugs absorption, distribution, binding to plasma 
proteins and elimination due to hydrophobic inter-
actions of the drug with biological targets and its 
penetration across biological membranes during 
transport. Lipophilic molecules exhibit better 
absorption, penetration into tissues and higher 
degree of distribution. Also, it is well-known that 
more lipophilic drugs exert a higher degree of protein 
binding in comparison to less lipophilic ones with 
similar properties (1-3).   
The plasma protein binding (PPB) degree 
significantly influences drugs efficiency. The less 
bound drug more efficiently passes through cell 
membranes or diffuses. Mainly, the unbound fraction 
actually exhibits pharmacologic effects. It is also the 
fraction that may be metabolized and/or excreted (4).    
Angiotensin-converting enzyme (ACE) inhibitors 
represent significant group of drugs widely used in 
the treatment of hypertension, congestive heart 
failure and renal failure. They were introduced in 
clinical practice three decades ago and today 
represent the most commonly prescribed antihyper-
tensive drugs (4-10).  
According to the available literature, a number 
of authors investigated the relationship between 
lipophilicity and ACE inhibitors pharmacological 
activity, duration of action and absorption (11-13). 
In our previous studies of ACE inhibitors, we 
reported their lipophilicity under different chromato-
graphic conditions (14-16), a relationship between 
chromatographic and in silico hydrophobicity 
parameters (17), as well as the correlation between 
UHPLC-MS and RP-TLC hydrophobicity data and ACE 
inhibitors absorption values (18). Conducting these 
researches, the aim of this study was to investigate the 
relationship between ACE inhibitors lipophilicity data 
(both calculated and chromatographically obtained) 
and their protein binding data. The main topic was to 
establish the approach capable for protein binding 
prediction of selected ACE inhibitors as well as the new 
synthesized drugs. 
 
Materials and methods 
 
Materials 
 
The following ACE inhibitors (Figure 1) were 
investigated:  
1. enalapril maleate, 2. quinapril hydro-
chloride, 3. fosinopril sodium, 4. lisinopril 
dihydrate, 5. cilazapril monohydrate, 6. ramipril 
and 7. benazepril hydrochloride.  Correlation between angiotensin-converting enzyme inhibitors...                                                                 Jadranka Odović et al. 
 
 
 
Figure 1. The chemical structure of investigated ACE inhibitors 
 
Methods 
 
The chromatographic conditions, ultra-high 
performance liquid chromatography-tandem mass 
spectrometry (UHPLC-MS) and reversed phase 
thin-layer chromatography (RP-TLC) for ACE 
inhibitors examination were reported previously 
(18). The UHPLC-MS investigations were carried 
out, as previously described (18) on a UHPLC-
MS/MS system consisting of a Thermo ACCELA 
UHPLC (Thermo Scientific, Waltham, Massa-
chusetts, USA) coupled to a triple quad Mass 
Spectrometer Thermo TSQ Quantum Access Max 
(Thermo Scientific, Waltham, Massachusetts, USA) 
with a heated electrospray ionization (HESI) 
interface. Samples were placed in thermostated 
autosampler at 4°C. A 10 μl samples were 
i n j e c t e d  o n t o  a  T h e r m o  H y p e r s i l  G o l d  c o l u m n  
(1.9μm, 50x2.1mm) and eluted at a tempe-
rature of 25°C and a flow rate of 300μl min
-1 by 
the use of binary solvent system (mobile phase A 
was 0.1% CH3COONH4 aqueous solution 
(pH=6.85), while mobile phase B was methanol) 
(18). The RP-TLC examinations were performed, 
as previously described on RP-18 silica gel plates 
with water-methanol binary solvent system (18).  
Reagents: ammonium acetate (Analytika, 
Ltd., Prague, Czech Republic), methanol (LC-MS 
Chromasolv, Sigma-Aldrich Steinhem, Germany) 
and deionized water (Gen Pure Ultrapure, Germany) 
where used throughout. Uracil (Merck, Darmstadt, 
Germany) was used for dead time determination 
(18).  
The Excel 2003 from Microsoft Office and 
Origin 7.0 PRO (Origin Lab Corporation, USA) 
were used to perform the statistical analysis of 
the regression. 
 
Results 
 
In this research, seven ACE inhibitors 
(enalapril, quinapril, fosinopril, lisinopril, cila-
zapril, ramipril, benazepril) were studied to 
evaluate the relationship between their protein 
binding and calculated (logP values) or ultra-high 
performance liquid chromatography-tandem mass 
spectrometry (UHPLC-MS) and reversed-phase 
thin-layer chromatography (RP-TLC) determined 
lipophilicity data (ϕ0, CHI or C0 parameters, 
respectively). Their protein binding data vary 
from negligible (lisinopril) to 99% (fosinopeil), 
while calculated logPKOWWIN values ranged from 
-0.94 (lisinopril) to 6.61 (fosinopril). 
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Table 1.The lipophilicity and protein binding data of selected ACE inhibitors 
 
ACE inhibitors  logPO/W log  PKOWWIN  Protein binding % 
Enalapril 2.45  2.45  55 
Quinapril 3.72  3.72  97 
Fosinopril 6.61  6.61  99 
Lisinopril -1.22  -0.94  0 
Cilazapril /  2.27  24 
Ramipril 3.32  3.32  73 
Benazepril 3.50  3.50  94 
 
Table 2. The hydrophobicity parameters of investigated ACE inhibitors obtained in UHPLC-MS and RP-TLC 
 
UHPLC-MS RP-TLC 
ACE inhibitors 
ϕ0  CHI C0 
Enalapril 0.533  0.537  0.596 
Quinapril 0.642  0.637  0.673 
Fosinopril 0.773  0.800  0.802 
Lisinopril 0.201  0.213  0.429 
Cilazapril 0.636  0.620  0.655 
Ramipril 0.615  0.610  0.660 
Benazepril 0.623  0.606  0.670 
 
The ACE inhibitors PPB data were (Table 1) 
were collected from relevant references (4).  
The experimentally determined logPO/W 
values (Table 1) of examined ACE inhibitors were 
obtained from Clarke’s Analysis of drugs and 
Poisons (19). The software packages Molinspiration 
(20), Virtual Computational Chemistry Laboratory 
(21) and CS Chem Office, version 7.0 (22) were 
used to calculate different ACE inhibitors 
lipophilicity descriptors, (in silico hydrophobicity 
parameters) computed logP values. 
  The ACE inhibitors hydrophobicity para-
meters,  ϕ0, CHI, and C0 values (Table 2) were 
chromatographically obtained in UHPLC-MS and 
RP-TLC investigations (18). 
 
Discussion 
   
This study included the most often pre-
scribed ACE inhibitors. In the first stage the 
selection of appropriate logP values was evaluated. 
The applied software packages (20-22) could 
calculate different logP values (milogP, AlogP, 
AClogP, XlogP, logPKOWWIN) of investigated ACE 
inhibitors.  
  The absolute calculated logP values were 
significantly different. In our previous paper the 
relationships between all collected logP values 
were studied. The selection of appropriate logP 
values was estimated on the basis of their 
agreement with experimentally determined 
partition coefficients logPO/W values (19). The 
logPKOWWIN values were selected for this study 
due to its best correlation (R
2=0.999) with the 
experimentally obtained ones logPO/W values (17). 
The logPKOWWIN values were also selected, since 
the best correlations were obtained between 
these values and chromatographically obtained 
hydrophobicity parameters, C0 ( R P - T L C )  a s  w e l l  
as ϕ0 or CHI (UHPLC-MS) (18). 
  In the next stage of this study, the 
relationship between calculated lipophilicity 
(logPKOWWIN values) and PPB data of examined 
ACE inhibitors was investigated and the following 
correlation was obtained: 
 
logPKOWWIN=0.0501(±0.0129)PPB–0.1734(±0.9351) 
...(1) 
n=7, R
2=0.7520 
 
The good correlation (Figire 2) was obtained as 
proposed (the range of R
2 0.49–0.79) in lite-
rature (23). 
 
 
Figure 2. The relationships between protein binding (%) 
and logPKOWWIN values (R
2=0.7520). The numbers 
denote substances used for linear regression 
 
As a final point, the possible correlations between 
chromatographically (UHPLC-MS or RP-TLC) obtained 
hydrophobicity parameters (ϕ0, CHI or C0) and 
protein binding data were studied.  
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ϕ0=0.0036(±0.0013)PPB+0.3461(±0.0929)...(2) 
n=7, R
2=0.6160  
CHI=0.0036(±0.0013)PPB+0.3454(±0.0915)...(3) 
n=7, R
2=0.6241  
C0=0.0023(±0.0007)PPB+0.4934(±0.0550)...(4) 
n=7, R
2=0.6547  
 
  All the correlations obtained can be 
considered as good, with acceptable F values due 
to limited number of compounds. The lipophilicity 
data both calculated as well as obtained with 
different chromatographic techniques, are capable 
of evaluating ACE inhibitors protein binding. 
However, the best relationship was observed 
between protein binding data and calculated 
logPKOWWIN values. The best correlation was found 
between in silico hydrophobicity parameters and 
protein binding data, thus confirming the 
calculation of logP as high-throughput screening 
technique for the evaluation of selected 
compounds protein binding degree.  
  It is generally accepted that increase in 
drugs lipophilicity led to increase of their 
absorption, distribution, activity and duration of 
action, but also to increase of drugs protein 
binding. Since high protein binding degree may 
cause decrease of drugs action and activity, the 
good balance between lipophilicity and protein 
binding should be established, especially in new 
synthesized drugs, for the patients’ benefits.  
 
  Conclusion  
  
  The discovery of new pharmacologically 
active substances and drugs modeling led to 
necessity of predicting drugs properties and its 
ADME data.  
  It was established that all ACE inhibitors 
lipophilicity data (calculated hydrophobicity para-
meters logPKOWWIN as well as chromatogra-
phically obtained parameters C0,  ϕ0 and CHI) 
correlate well with protein binding values. The 
proposed model based on hydrophobicity data, 
calculated or chromatographically obtained, is 
capable of evaluating ACE inhibitors protein 
binding values. The possible application of 
computed logP values in drugs protein binding 
evaluation is of great importance in drug 
research. 
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ZAVISNOST LIPOFILNOSTI I VEZIVANJA ZA PROTEINE PLAZME 
INHIBITORA ANGIOTENZIN KONVERTUJUĆEG ENZIMA 
 
Jadranka Odović i Jasna Trbojević-Stanković 
 
 
Inhibitori angiotenzin konvertujućeg enzima (ACE inhibitori) predstavljaju veliku 
grupu lekova koji nalaze primenu u lečenju hipertenzije. U ovom radu analizirano je 
sedam ACE inhibitora (enalapril, kvinapril, fosinopril, lizinopril, cilazapril, ramipril i 
benazepril) kako bi se ispitala zavisnost između njihovog vezivanja za proteine plazme 
i lipofilnosti. Korelisane su vrednosti izračunatih (logPKOWWIN) ili hromatografski (UHPLC-
MS i RP-TLC) dobijenih (ϕ0, CHI ili C0) hidrofobnih parametara. Procenat vezivanja za 
proteine plazme ispitivanih ACE inhibitora kretao se u opsegu od 0% do 99%, dok su 
vrednosti izračunatih logPKOWWIN vrednosti iznosile od -0.94 do 6.61. Dobijene su 
zadovoljavajuće korelacije između vrednosti vezivanja ACE inhibitora za proteine 
plazme i izračunatih logPKOWWIN vrednosti (R
2=0,7520) kao i hromatografski dobijenih 
parametara hidrofobnosti, ϕ0, CHI, C0 (R
2: 0,6160; 0,6242; 0,6547). Acta Medica 
Medianae 2012;51(4):13-18. 
 
Ključne reči:  inhibitori angiotenzin konvertujućeg enzima (ACE inhibitori), 
vezivanje za proteine plazme, lipofilnost 